[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356895-105":59,"doc-detail-356895-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","an-ai-derived-peptide-pca2-suppresses-pancreatic-cancer-growth-via-modulation-of-the-erbbpi3kaktmtormyc-signaling-axis","An AI-derived peptide PCa2 suppresses pancreatic cancer growth via modulation of the ErbB/PI3K/AKT/mTOR/MYC signaling axis","","Pancreatic cancer remains a highly lethal malignancy with limited therapeutic options, motivating the search for innovative antitumor strategies. The study reports PCa2, an AI-derived anticancer lead peptide from the Candida albicans genome, showing potent activity against pancreatic cancer in vitro and in vivo. Mechanistic results indicate PCa2 modulation of the ErbB–PI3K–AKT–mTOR–MYC signaling axis with receptor internalization and lysosome-mediated degradation, promoting autophagy-associated cytotoxicity.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-ai-derived-peptide-pca2-suppresses-pancreatic-cancer-growth-via-modulation-of-the-erbbpi3kaktmtormyc-signaling-axis/356895/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-ai-derived-peptide-pca2-suppresses-pancreatic-cancer-growth-via-modulation-of-the-erbbpi3kaktmtormyc-signaling-axis/356895.png","ImageObject",300,407,{"name":92,"@type":93},"Stanford","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is PCa2 in this research?","Question",{"text":113,"@type":114},"PCa2 is an AI-derived anticancer lead peptide originating from the Candida albicans genome.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does PCa2 suppress pancreatic cancer growth?",{"text":118,"@type":114},"The study links PCa2 activity to modulation of the ErbB–PI3K–AKT–mTOR–MYC signaling axis, alongside receptor internalization and lysosome-mediated degradation.",{"name":120,"@type":111,"acceptedAnswer":121},"Where was PCa2 activity demonstrated?",{"text":122,"@type":114},"PCa2 shows potent antitumor effects against pancreatic cancer in vitro and in vivo, and the authors discuss extending effects beyond prior observations in colon cancer.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356895,1790167492,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Zuo etal. Cell Communication and Signaling (2026) 24:315  \n[https://doi.org/10.1186/s12964-026-02856-6](https://doi.org/10.1186/s12964-026-02856-6)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nAn AI-derived peptide PCa2 suppresses pancreatic cancer growth via modulation ofthe ErbB/PI3K/AKT/mTOR/MYC signaling axis  \nWeimin Zuo1,2,3, Siyuan Luo3, Haixin Qin3, Koon Ho Wong1,2,3, Shirley W. I. Siu4, Alexandre K. Tashima5, Yehuda G. Assaraf6 and Hang Fai Kwok 1,2,3*  \nAbstract  \nPancreatic cancer remains a highly lethal malignancy with limited therapeutic options, calling for innovative discovery of efficacious antitumor strategies. Here, we report on PCa2, an AI-derived anticancer lead peptide originating from the Candida albicans genome, which exhibits potent antitumor activity against pancreatic cancer both in vitro and in vivo. Mechanistic investigations suggest that PCa2 is associated with modulation of the ErbB– PI3K–AKT–mTOR–MYC signaling axis, accompanied by receptor internalization and lysosome-mediated degradation. Collectively, these findings identify PCa2 as a promising therapeutic lead candidate that modulates the ErbB–PI3K– AKT–mTOR-MYC axis and induces autophagy-associated cytotoxicity in pancreatic cancer.  \nKeywords Pancreatic cancer, Anticancer peptides, Pipeline, ErbB signaling  \nIntroduction  \nPancreatic cancer is considered a representative of the leading deadly and fast-progressing cancers, ranking as the seventh primary contributor to cancer mortality globally [1, 2]. With the survival rate limited to 11% over five years, pancreatic cancer represents a significant clinical challenge [3, 4]. This dismal prognosis can be owing to delayed discovery, fast disease development, coupled with drug resistance to traditional treatments [5, 6]. Despite advancements in treatment, effective therapeutic options remain limited, underscoring the pressing  \n*Correspondence: Hang Fai Kwok [hfkwok@um.edu. mo](hfkwok@um.edu. mo)  \nFull list of author information is available at the end of the article  \ndemand for innovative strategies to enhance clinical results for patients [7, 8].  \nAmong emerging therapeutic strategies, anti-cancer peptides (ACPs) have garnered increasing attention due to their unique capability to target malignant cells while sparing healthy cells from toxicity [9–11]. ACPs are short bioactive molecules with different modes of effect, such as disruption of cellular membranes, modulation of intracellular signaling pathways, and triggering programmed cell death processes, including apoptosis as well as autophagy [10]. These properties render ACPs highly promising candidates for cancer therapy. Recent advances in computational biology and artificial intelligence (AI) provide an opportunity to accelerate the discovery of bioactive peptides with therapeutic potential [12–15]. Through a multi-tier AI-assisted screening and prioritization pipeline, we previously identified PCa2,  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/","cbCailAQVzLezK7R","https://ap.wps.com/l/cbCailAQVzLezK7R","pdf",11820800,"English","# Introduction\n## Background on pancreatic cancer\n## Anti-cancer peptides and AI-assisted discovery","[{\"question\":\"What is PCa2 in this research?\",\"answer\":\"PCa2 is an AI-derived anticancer lead peptide originating from the Candida albicans genome.\"},{\"question\":\"How does PCa2 suppress pancreatic cancer growth?\",\"answer\":\"The study links PCa2 activity to modulation of the ErbB–PI3K–AKT–mTOR–MYC signaling axis, alongside receptor internalization and lysosome-mediated degradation.\"},{\"question\":\"Where was PCa2 activity demonstrated?\",\"answer\":\"PCa2 shows potent antitumor effects against pancreatic cancer in vitro and in vivo, and the authors discuss extending effects beyond prior observations in colon cancer.\"}]","An AI-derived peptide PCa2 suppresses pancreatic cancer growth via modulation of the ErbB/PI3K/AKT/mTOR/MYC signaling axis | PDF",1790128141,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c97df184236717ea2ecf97d693e6007.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3099f28a05f29840b054fc5bc747da3c.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11738f9bc67cf4ed09ccc73fe583102d.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/080ff8af25fa41f23f3180c80d781aee.webp",980,1306]